Steris PLC (NYSE:STE) Director Sells $516,993.65 in Stock

Share on StockTwits

Steris PLC (NYSE:STE) Director Mohsen Sohi sold 3,121 shares of the firm’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $165.65, for a total transaction of $516,993.65. Following the completion of the sale, the director now directly owns 25,482 shares of the company’s stock, valued at $4,221,093.30. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

NYSE:STE opened at $168.51 on Friday. The company has a 50-day moving average price of $153.20 and a 200-day moving average price of $149.19. Steris PLC has a 12 month low of $118.18 and a 12 month high of $168.61. The company has a current ratio of 2.41, a quick ratio of 1.86 and a debt-to-equity ratio of 0.73. The stock has a market cap of $14.29 billion, a price-to-earnings ratio of 36.63 and a beta of 0.90.

Steris (NYSE:STE) last issued its quarterly earnings results on Monday, February 10th. The medical equipment provider reported $1.45 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.42 by $0.03. The company had revenue of $774.30 million during the quarter, compared to analyst estimates of $748.45 million. Steris had a net margin of 13.21% and a return on equity of 17.32%. Steris’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same period last year, the business earned $1.26 EPS. Equities analysts forecast that Steris PLC will post 5.58 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, February 25th will be paid a $0.37 dividend. The ex-dividend date is Monday, February 24th. This represents a $1.48 annualized dividend and a dividend yield of 0.88%. Steris’s payout ratio is 30.27%.

Several research firms have recently commented on STE. Northcoast Research reaffirmed a “buy” rating on shares of Steris in a research report on Wednesday. Stephens raised their target price on shares of Steris from $165.00 to $177.00 and gave the stock an “overweight” rating in a research report on Wednesday. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $152.75.

Several institutional investors have recently modified their holdings of STE. Pictet Asset Management Ltd. bought a new position in shares of Steris in the 4th quarter worth about $131,374,000. State Street Corp increased its stake in Steris by 27.5% during the 4th quarter. State Street Corp now owns 3,587,820 shares of the medical equipment provider’s stock valued at $546,856,000 after purchasing an additional 774,516 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Steris by 132.5% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,053,593 shares of the medical equipment provider’s stock valued at $160,588,000 after purchasing an additional 600,507 shares in the last quarter. BlackRock Inc. increased its stake in Steris by 6.1% during the 2nd quarter. BlackRock Inc. now owns 9,052,709 shares of the medical equipment provider’s stock valued at $1,347,769,000 after purchasing an additional 522,254 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its stake in Steris by 14.6% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 1,950,497 shares of the medical equipment provider’s stock valued at $297,294,000 after purchasing an additional 248,912 shares in the last quarter. Institutional investors own 86.78% of the company’s stock.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Recommended Story: Why are percentage gainers important?

Insider Buying and Selling by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.